New method of classifying infections in critically ill patients

Critical Care Medicine
Jonathan CohenSteven M Opal

Abstract

To develop a systematic classification describing the contribution made by infection to the outcome from sepsis. The emergence of effective therapies for sepsis means that accurate methods of risk assessment are of increasing importance. Although there are well-validated instruments for describing risk factors in the host, the contribution made by the infection is less well served. A systematic literature review of the English language literature published during the last 30 yrs of studies describing the outcome of infections, categorized by micro-organism and site of infection. We surveyed 510 published articles including 55,854 clinical infections, and we generated specific risk codes for bacteremia, meningitis, pneumonia, skin and soft tissue infections, peritonitis, and urinary tract infections. Both the nature of the organisms and the site of infection have a significant impact on survival from sepsis, and there is a significant interaction between them. We have described a novel approach to permit a better assessment of the contribution made by the infection to mortality in patients with sepsis or septic shock.

References

Jan 1, 1991·Reviews of Infectious Diseases·F J RobertsA Coldman
Oct 1, 1985·Critical Care Medicine·W A KnausJ E Zimmerman
Oct 1, 1995·Critical Care Medicine·J C MarshallW J Sibbald
Sep 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J Y FagonC Gibert
Apr 8, 1999·American Journal of Respiratory and Critical Care Medicine·D K HeylandC Brun-Buisson
May 26, 1999·Infectious Disease Clinics of North America·S M Opal, A S Cross
May 26, 1999·Infectious Disease Clinics of North America·M S Rangel-Frausto
Jul 8, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·L SoufirS Chevret
Mar 10, 2001·The New England Journal of Medicine·G R BernardUNKNOWN Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group
Apr 17, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L A MermelUNKNOWN Society for Healthcare Epidemiology of America
Mar 22, 2002·Intensive Care Medicine·Corinne AlbertiRoger Le Gall
Apr 12, 2003·Critical Care Medicine·Mitchell M LevyUNKNOWN SCCM/ESICM/ACCP/ATS/SIS
Apr 18, 2003·The New England Journal of Medicine·Greg S MartinMarc Moss

❮ Previous
Next ❯

Citations

Aug 29, 2006·Current Infectious Disease Reports·Donald C Vinh, John M Embil
Sep 21, 2007·Current Infectious Disease Reports·Donald C Vinh, John M Embil
Oct 21, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jean-Francois DhainautDavid R Nelson
Jul 9, 2004·Critical Care Medicine·Jean-François Timsit
Apr 29, 2005·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Steven M Opal
Apr 24, 2008·Critical Care Medicine·Jean CarletHenry Masur
Apr 15, 2006·Clinical Microbiology Reviews·Deirdre ChurchRobert Lindsay
Oct 22, 2005·American Journal of Respiratory and Critical Care Medicine·Jean-Louis Vincent, Edward Abraham
Sep 8, 2011·BMC Infectious Diseases·Philippe VanhemsJacqueline Grando
Oct 1, 2013·Critical Care : the Official Journal of the Critical Care Forum·Nicolas de ProstChristian Brun-Buisson
Jul 1, 2005·Critical Care : the Official Journal of the Critical Care Forum·Saad NseirAlain Durocher
May 2, 2015·The Lancet Infectious Diseases·Jonathan CohenEric Pelfrene
Dec 18, 2013·Virulence·Florian B MayrDerek C Angus
Sep 13, 2016·Chest·Shipra GuptaKianoush B Kashani
Mar 28, 2008·Revista Da Sociedade Brasileira De Medicina Tropical·Aline Pâmela Vieira de OliveiraBeatriz Martins Tavares-Murta
Sep 18, 2014·Critical Care Medicine·Chizobam AniH Bryant Nguyen
Feb 18, 2016·Journal of Intensive Care Medicine·Christine A Motzkus, Roger Luckmann
Aug 20, 2019·Chinese Medical Journal·Hong-Cheng TianUNKNOWN for China Critical Care Clinical Trials Group (CCCCTG)
Aug 18, 2020·Journal of Intensive Care Medicine·Rahul D PawarAri Moskowitz
Jun 27, 2019·Journal of Innate Immunity·Adam LinderJames A Russell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.